TY - JOUR
TI - Prevalence of diabetes and pre-diabetes in Greece. Results of the First National Survey of Morbidity and Risk Factors (EMENO) study
AU - Makrilakis, K.
AU - Kalpourtzi, N.
AU - Ioannidis, I.
AU - Iraklianou, S.
AU - Raptis, A.
AU - Sotiropoulos, A.
AU - Gavana, M.
AU - Vantarakis, A.
AU - Kantzanou, M.
AU - Hadjichristodoulou, C.
AU - Chlouverakis, G.
AU - Trypsianis, G.
AU - Voulgari, P.V.
AU - Alamanos, Y.
AU - Touloumi, G.
AU - Liatis, S.
JO - Diabetes Research and Clinical Practice
PY - 2021
VL - 172
TODO - null
SP - null
PB - Elsevier Ireland Ltd
SN - 0168-8227
TODO - 10.1016/j.diabres.2020.108646
TODO - dipeptidyl peptidase IV inhibitor;  glucose;  hemoglobin A1c;  insulin;  metformin;  sulfonylurea, adult;  age distribution;  aged;  Article;  body weight;  controlled study;  diabetes mellitus;  female;  geriatrics;  glucose blood level;  Greece;  Greek (people);  groups by age;  health service;  human;  impaired glucose tolerance;  major clinical study;  male;  prevalence;  risk factor;  sex ratio;  wellbeing;  adolescent;  cross-sectional study;  diabetes mellitus;  impaired glucose tolerance;  middle aged;  morbidity;  mortality;  prevalence;  questionnaire;  young adult, Adolescent;  Adult;  Aged;  Cross-Sectional Studies;  Diabetes Mellitus;  Female;  Greece;  Humans;  Male;  Middle Aged;  Morbidity;  Prediabetic State;  Prevalence;  Risk Factors;  Surveys and Questionnaires;  Young Adult
TODO - Aims: To report the results of the first national Health Examination Survey (HES) on the prevalence of diabetes, its pharmacologic treatment and level of control, as well as pre-diabetes in Greece. Methods: Data were derived from the National Survey of Morbidity and Risk Factors (EMENO), in a randomly selected, representative sample of the adult Greek population. Sampling weights were applied to adjust for study design and post-stratification weights to match sample age/sex distribution to the population. Non-response was adjusted by inverse probability weighting. Weighted prevalence estimates are provided. Results: A total of 4393 persons with HbA1c and/or fasting plasma glucose measurements were included. Total diabetes prevalence was 11.9% (95% CI: 10.9–12.9), known diabetes 10.4% (9.5–11.4), and unknown 1.5% (1.1–1.9), with considerable increase in older age groups and no difference between genders. Pre-diabetes prevalence was 12.4% (11.4–13.6). The majority of persons with known diabetes were receiving metformin. Of those with known diabetes (and measured HbA1c), 70.9% were well controlled (HbA1c <7.0%). Conclusions: This first representative national HES showed high prevalence of diabetes in Greece, with low prevalence of unknown diabetes. Pre-diabetes prevalence is also substantial. These results will hopefully enable national authorities develop tailored and efficient strategies for disease prevention and management. © 2020
ER -